Device / Technology News

RSS

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound is a highly effective technology developed to complement mammography in women with radiologically dense breasts and other risk factors.

7 Jul 2010

Electronic braking system increases safety of walkers for senior citizens

Rolling walkers - which help senior citizens maintain mobility and an active lifestyle - have just become safer and easier to use.

7 Jul 2010

Robots help remove diseased thyroid gland without neck incision

Robots that revolutionized gynecologic and urologic surgery in the past decade now offer the option of removing at least a portion of their diseased thyroid gland without the hallmark neck incision, researchers said.

7 Jul 2010

Stand-By Systems now eligible to sell products to federal government

Emerging Healthcare Solutions, Inc. disclosed today that Stand-By Systems has favorably completed their US Government Central Contractor Registration and is now eligible to sell their breakthrough products to the federal government. EHSI has verified the federal eligibility as part of their due diligence related to an option with Stand-By Systems (SBS), owner of the FDA approved SBS 1615 catalytic oxygen generator and associated systems. The option agreement allows EHSI management to perform due diligence prior to finalizing a definitive agreement.

7 Jul 2010

OTN signs agreement to integrate PharmaTrust's technology into telemedicine service offering

PharmaTrust, makers of the world's leading remote prescription drug dispensing technology, has signed an agreement with the Ontario Telemedicine Network that will enable OTN's Members, including hospitals, to integrate PharmaTrust's technology into their telemedicine service offering. This new development will expand access to valuable pharmacy services for Ontarians.

7 Jul 2010

TGen develops G-SQZ technique for genomic data processing

A new computer data compression technique called Genomic SQueeZ, developed by the Translational Genomics Research Institute, will allow genetic researchers and others to store, analyze and share massive volumes of data in less space and at lower cost.

7 Jul 2010

Medicare reimbursement rates for outpatient repair of anal fistulas increased by 6%

Hospitals nationwide will receive six percent higher reimbursement payments for outpatient repair of anal fistulas using Cook Medical's Biodesign® Fistula Plug, a device designed specifically to treat this painful and embarrassing disorder of the lower GI tract. According to new Medicare payment schedules effective January 1st, hospital outpatient surgery departments will receive approximately $2,200 per procedure, while freestanding ambulatory surgery centers will be paid about $1,300 on average.

7 Jul 2010

Cedars-Sinai Heart Institute awarded grant to develop new system to predict sudden cardiac arrest

The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.

7 Jul 2010

QIAGEN receives CE conformity marking for careHPV Test

QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.

From QIAGEN Manchester Limited 7 Jul 2010

Cambridge Heart commences enrollment in study to identify ischemia in patients with coronary artery disease

Cambridge Heart, Inc., today announced the first patient enrollments in the MTWA-CAD study (Evaluation of Microvolt T-Wave Alternans Testing for the Detection of Active Ischemia in Patients with Known or Suspected Coronary Artery Disease).

7 Jul 2010

FDA approves IMT to improve vision in patients with end-stage AMD

The U.S. Food and Drug Administration today announced it has approved the Implantable Miniature Telescope to improve vision in some patients with end-stage age-related macular degeneration.

7 Jul 2010

Washington Post examines birth simulator for health worker training in developing world

A new device which simulates childbirth on a real woman could help train health workers to deliver babies and deal with complications, according to the Washington Post, which adds that the $100 low-tech "frontpack" is called "'MamaNatalie,' a name that plays on 'natalis,' which means 'pertaining to birth' in Latin."

7 Jul 2010

Dell hedging on health IT investment; Privacy concerns remain

The Wall Street Journal: Dell is hoping to capitalize on its purchase of health technology firm Perot Systems by providing services to new clients such as the 2,600-doctor Methodist Hospital System in Houston. Dell has contracted to create an electronic medical records system for Methodist, a new foray into IT services for the hardware-focused firm.

7 Jul 2010

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

In lab experiments, the researchers have found that this device, a vector, is able to deliver DNA deeply enough into a cell to allow genetic material to be activated - a critical step in gene therapy. This vector is between 2 - and 10 times more effective than other experimental materials, according to the research.

7 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter which is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). It is the first VCF to be developed that is bidirectional and thus permits insertion or retrieval from either the femoral or jugular veins.

7 Jul 2010

Cornerstone reacquires all development, commercial rights to HMGB1 related technology from MedImmune

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has reacquired all development and commercial rights to its high-mobility group box protein 1 (HMGB1) related technology from MedImmune, LLC.

6 Jul 2010

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Sangamo BioSciences, Inc. announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on its proprietary zinc finger DNA-binding protein nuclease (ZFN) technology.

6 Jul 2010

IRIS wins Premier healthcare alliance's fifth annual Pinnacle Award

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it is the winner of the fifth annual Pinnacle Award presented by the Premier healthcare alliance.

6 Jul 2010

CPRIT grants RBM $3 million Company Commercialization Award to expand OncologyMAP program

Rules-Based Medicine, Inc. (RBM) today announced the Cancer Prevention and Research Institute of Texas (CPRIT) has granted it a Company Commercialization Award to expand and enhance the OncologyMAP™ program for discovery and development of novel diagnostic and prognostic cancer tests. The award of approximately $3 million will fund research and development to more than double the number of cancer-associated biomarker assays in RBM's new OncologyMAP™ product.

6 Jul 2010

Device / Technology News

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Electronic braking system increases safety of walkers for senior citizens

Robots help remove diseased thyroid gland without neck incision

Stand-By Systems now eligible to sell products to federal government

OTN signs agreement to integrate PharmaTrust's technology into telemedicine service offering

TGen develops G-SQZ technique for genomic data processing

Medicare reimbursement rates for outpatient repair of anal fistulas increased by 6%

Cedars-Sinai Heart Institute awarded grant to develop new system to predict sudden cardiac arrest

QIAGEN receives CE conformity marking for careHPV Test

Cambridge Heart commences enrollment in study to identify ischemia in patients with coronary artery disease

FDA approves IMT to improve vision in patients with end-stage AMD

Washington Post examines birth simulator for health worker training in developing world

Dell hedging on health IT investment; Privacy concerns remain

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Cornerstone reacquires all development, commercial rights to HMGB1 related technology from MedImmune

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

IRIS wins Premier healthcare alliance's fifth annual Pinnacle Award

CPRIT grants RBM $3 million Company Commercialization Award to expand OncologyMAP program

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News